Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries

Emilie Vessières, Eric Jacques Belin de Chantemele, Anne Laure Guihot, Alain Jardel, Bertrand Toutain, Laurent Loufrani, Daniel Henrion

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Obesity is associated with altered arterial structure and function leading to arterial narrowing in most vascular beds, especially when associated with aging. Nevertheless, mesenteric blood flow remains elevated in obese rats, although the effect of aging remains unknown. We investigated mesenteric artery narrowing following blood flow reduction in vivo in 3- and 12-month-old obese Zucker rats.After 21. days, inward remodeling occurred in low flow (LF) arteries in young and old lean rats and in young obese rats (30% diameter reduction). Diameter did not significantly decrease in old obese rats. Phenylephrine-mediated contraction was reduced by approximately 20% in LF arteries in all groups but in old obese rat arteries in which the decrease reached 80%. LF arteries expressed cyclooxygenase-2 and blood 6-keto-PGF1alpha (prostacyclin metabolite) was elevated in old obese rats. In old obese rats, acute cyclooxygenase-2 blockade restored phenylephrine-mediated contraction in LF arteries and chronic cyclooxygenase-2 blockade restored inward remodeling and contractility to control level.Thus, in old obese rats, cyclooxygenase-2-derived prostacyclin prevented the diameter reduction induced by a chronic decrease in blood flow. This adaptation is in favor of a preserved perfusion of the mesentery by contrast with other vascular territories, possibly amplifying the vascular disorders occurring in obesity.

Original languageEnglish (US)
Pages (from-to)356-362
Number of pages7
JournalVascular Pharmacology
Volume58
Issue number5-6
DOIs
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Zucker Rats
Mesenteric Arteries
Cyclooxygenase 2
Prostaglandins
Arteries
Blood Vessels
Phenylephrine
Epoprostenol
Obesity
Mesentery
Perfusion

Keywords

  • Blood flow
  • Cyclooxygenase-2
  • Metabolic syndrome
  • Remodeling
  • Resistance arteries

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Physiology

Cite this

Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries. / Vessières, Emilie; Belin de Chantemele, Eric Jacques; Guihot, Anne Laure; Jardel, Alain; Toutain, Bertrand; Loufrani, Laurent; Henrion, Daniel.

In: Vascular Pharmacology, Vol. 58, No. 5-6, 01.05.2013, p. 356-362.

Research output: Contribution to journalArticle

Vessières, Emilie ; Belin de Chantemele, Eric Jacques ; Guihot, Anne Laure ; Jardel, Alain ; Toutain, Bertrand ; Loufrani, Laurent ; Henrion, Daniel. / Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries. In: Vascular Pharmacology. 2013 ; Vol. 58, No. 5-6. pp. 356-362.
@article{03bdeb59c1e0405cb1ef3c7a5d9d3074,
title = "Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries",
abstract = "Obesity is associated with altered arterial structure and function leading to arterial narrowing in most vascular beds, especially when associated with aging. Nevertheless, mesenteric blood flow remains elevated in obese rats, although the effect of aging remains unknown. We investigated mesenteric artery narrowing following blood flow reduction in vivo in 3- and 12-month-old obese Zucker rats.After 21. days, inward remodeling occurred in low flow (LF) arteries in young and old lean rats and in young obese rats (30{\%} diameter reduction). Diameter did not significantly decrease in old obese rats. Phenylephrine-mediated contraction was reduced by approximately 20{\%} in LF arteries in all groups but in old obese rat arteries in which the decrease reached 80{\%}. LF arteries expressed cyclooxygenase-2 and blood 6-keto-PGF1alpha (prostacyclin metabolite) was elevated in old obese rats. In old obese rats, acute cyclooxygenase-2 blockade restored phenylephrine-mediated contraction in LF arteries and chronic cyclooxygenase-2 blockade restored inward remodeling and contractility to control level.Thus, in old obese rats, cyclooxygenase-2-derived prostacyclin prevented the diameter reduction induced by a chronic decrease in blood flow. This adaptation is in favor of a preserved perfusion of the mesentery by contrast with other vascular territories, possibly amplifying the vascular disorders occurring in obesity.",
keywords = "Blood flow, Cyclooxygenase-2, Metabolic syndrome, Remodeling, Resistance arteries",
author = "Emilie Vessi{\`e}res and {Belin de Chantemele}, {Eric Jacques} and Guihot, {Anne Laure} and Alain Jardel and Bertrand Toutain and Laurent Loufrani and Daniel Henrion",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.vph.2013.03.001",
language = "English (US)",
volume = "58",
pages = "356--362",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries

AU - Vessières, Emilie

AU - Belin de Chantemele, Eric Jacques

AU - Guihot, Anne Laure

AU - Jardel, Alain

AU - Toutain, Bertrand

AU - Loufrani, Laurent

AU - Henrion, Daniel

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Obesity is associated with altered arterial structure and function leading to arterial narrowing in most vascular beds, especially when associated with aging. Nevertheless, mesenteric blood flow remains elevated in obese rats, although the effect of aging remains unknown. We investigated mesenteric artery narrowing following blood flow reduction in vivo in 3- and 12-month-old obese Zucker rats.After 21. days, inward remodeling occurred in low flow (LF) arteries in young and old lean rats and in young obese rats (30% diameter reduction). Diameter did not significantly decrease in old obese rats. Phenylephrine-mediated contraction was reduced by approximately 20% in LF arteries in all groups but in old obese rat arteries in which the decrease reached 80%. LF arteries expressed cyclooxygenase-2 and blood 6-keto-PGF1alpha (prostacyclin metabolite) was elevated in old obese rats. In old obese rats, acute cyclooxygenase-2 blockade restored phenylephrine-mediated contraction in LF arteries and chronic cyclooxygenase-2 blockade restored inward remodeling and contractility to control level.Thus, in old obese rats, cyclooxygenase-2-derived prostacyclin prevented the diameter reduction induced by a chronic decrease in blood flow. This adaptation is in favor of a preserved perfusion of the mesentery by contrast with other vascular territories, possibly amplifying the vascular disorders occurring in obesity.

AB - Obesity is associated with altered arterial structure and function leading to arterial narrowing in most vascular beds, especially when associated with aging. Nevertheless, mesenteric blood flow remains elevated in obese rats, although the effect of aging remains unknown. We investigated mesenteric artery narrowing following blood flow reduction in vivo in 3- and 12-month-old obese Zucker rats.After 21. days, inward remodeling occurred in low flow (LF) arteries in young and old lean rats and in young obese rats (30% diameter reduction). Diameter did not significantly decrease in old obese rats. Phenylephrine-mediated contraction was reduced by approximately 20% in LF arteries in all groups but in old obese rat arteries in which the decrease reached 80%. LF arteries expressed cyclooxygenase-2 and blood 6-keto-PGF1alpha (prostacyclin metabolite) was elevated in old obese rats. In old obese rats, acute cyclooxygenase-2 blockade restored phenylephrine-mediated contraction in LF arteries and chronic cyclooxygenase-2 blockade restored inward remodeling and contractility to control level.Thus, in old obese rats, cyclooxygenase-2-derived prostacyclin prevented the diameter reduction induced by a chronic decrease in blood flow. This adaptation is in favor of a preserved perfusion of the mesentery by contrast with other vascular territories, possibly amplifying the vascular disorders occurring in obesity.

KW - Blood flow

KW - Cyclooxygenase-2

KW - Metabolic syndrome

KW - Remodeling

KW - Resistance arteries

UR - http://www.scopus.com/inward/record.url?scp=84877594328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877594328&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2013.03.001

DO - 10.1016/j.vph.2013.03.001

M3 - Article

C2 - 23524072

AN - SCOPUS:84877594328

VL - 58

SP - 356

EP - 362

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5-6

ER -